Abstract
Background: The prognosis for children with M1 medulloblastoma (positive CSF cytology) has not been well-defin ed. Methods: We retrospectively reviewed the records of 285 newly diagnosed medulloblastoma patients treated between 1984 and 2006. Older children received post-operative craniospinal and tumor bed irradiation; radiotherapy for younger children depended on treatment era and physician/family preference. Results: 55 patients were <3 years old and 230 patients were >3 years old at diagnosis. We detected significant (P < 0.0001) associations between M1 disease and EFS for the entire cohort and for both younger and older patients. Among younger children, M1 patients had lower EFS than M0 (P = 0.0044). Conclusions : Children <3 years old with M1 medulloblastoma fared poorly in our small series. Survival for older children with M1 disease treated with higher-dose CSI was better than that of M2/M3 patients, but still less than optimal; our findings do not support reduction in therapy for either cohort.
Original language | English (US) |
---|---|
Pages (from-to) | 351-355 |
Number of pages | 5 |
Journal | Journal of Neuro-Oncology |
Volume | 90 |
Issue number | 3 |
DOIs | |
State | Published - 2008 |
Keywords
- Cytology
- Infant
- Medulloblastoma
- Metastatic
- Prognosis
- Survival
ASJC Scopus subject areas
- Oncology
- Neurology
- Clinical Neurology
- Cancer Research